Enfusion, Inc. financial data

Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2024 - 03 Mar 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 376% % -13%
Debt-to-equity 53% % 11%
Return On Equity 3.1% % -59%
Return On Assets 2.2% % -61%
Operating Margin 3% % -55%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $419,300,000 USD -4.3%
Weighted Average Number of Shares Outstanding, Basic 92,045,000 shares 4.4%
Weighted Average Number of Shares Outstanding, Diluted 129,550,000 shares 0.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $201,611,000 USD 16%
Cost of Revenue $64,874,000 USD 13%
Selling and Marketing Expense $25,029,000 USD 23%
General and Administrative Expense $78,826,000 USD 22%
Operating Income (Loss) $6,155,000 USD -48%
Nonoperating Income (Expense) $1,234,000 USD 1800%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,389,000 USD -36%
Income Tax Expense (Benefit) $3,474,000 USD 56%
Net Income (Loss) Attributable to Parent $2,823,000 USD -53%
Earnings Per Share, Basic 0 USD/shares -57%
Earnings Per Share, Diluted 0 USD/shares -57%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $54,480,000 USD 53%
Accounts Receivable, after Allowance for Credit Loss, Current $31,988,000 USD 14%
Other Assets, Current $1,711,000 USD 46%
Assets, Current $93,521,000 USD 34%
Property, Plant and Equipment, Net $20,963,000 USD 14%
Operating Lease, Right-of-Use Asset $18,062,000 USD 26%
Other Assets, Noncurrent $7,715,000 USD 19%
Assets $143,261,000 USD 31%
Accounts Payable, Current $867,000 USD -61%
Liabilities, Current $27,336,000 USD 35%
Operating Lease, Liability, Noncurrent $14,236,000 USD 27%
Other Liabilities, Noncurrent $2,150,000 USD
Liabilities $43,722,000 USD 39%
Accumulated Other Comprehensive Income (Loss), Net of Tax $734,000 USD -81%
Retained Earnings (Accumulated Deficit) $170,109,000 USD 1.6%
Stockholders' Equity Attributable to Parent $73,221,000 USD 36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $99,539,000 USD 28%
Liabilities and Equity $143,261,000 USD 31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,533,000 USD 66%
Net Cash Provided by (Used in) Financing Activities $1,373,000 USD 78%
Net Cash Provided by (Used in) Investing Activities $2,748,000 USD -7.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,710,000 USD 66%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $54,480,000 USD 53%
Deferred Tax Assets, Valuation Allowance $149,718,000 USD 6.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $149,718,000 USD 6.7%
Operating Lease, Liability $20,312,000 USD 32%
Payments to Acquire Property, Plant, and Equipment $635,000 USD -57%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,495,000 USD -59%
Lessee, Operating Lease, Liability, to be Paid $23,274,000 USD 28%
Property, Plant and Equipment, Gross $46,643,000 USD 33%
Operating Lease, Liability, Current $6,076,000 USD 43%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,380,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,765,000 USD 30%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,962,000 USD 7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,488,000 USD 70%
Deferred Tax Assets, Operating Loss Carryforwards $14,506,000 USD 27%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $1,948,000 USD 516%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,976,000 USD -8.5%
Additional Paid in Capital $243,935,000 USD 7.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,674,000 USD 43%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%